Invention Grant
- Patent Title: Anti-CD46 antibodies and methods of use
-
Application No.: US16348135Application Date: 2017-11-10
-
Publication No.: US11434301B2Publication Date: 2022-09-06
- Inventor: Bin Liu , Daniel W. Sherbenou , Blake T. Aftab , Yang Su , Christopher R. Behrens
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Weaver Austin Villeneuve & Sampson LLP
- Agent Tom Hunter
- International Application: PCT/US2017/061124 WO 20171110
- International Announcement: WO2018/089807 WO 20180517
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; A61P35/00 ; C07K16/30 ; C12Q1/6886 ; C07K16/00 ; G01N33/574 ; A61K39/00
Abstract:
Disclosed herein are methods of treating a subject having a cancer characterized by a modification at biomarker 1q21, which comprises administering to the subject a therapeutically effective amount of an anti-CD46 antibody.
Public/Granted literature
- US20190276553A1 ANTI-CD46 ANTIBODIES AND METHODS OF USE Public/Granted day:2019-09-12
Information query
